Evaluate the Safety, Tolerability, Pharmacokinetic Characteristics and Preliminary Efficacy of HLX26 and HLX10 in Patients With Advanced/Metastatic Solid Tumor
Clinical trial NCT05400265 · COMPLETED
Trial details
- NCT number
- NCT05400265
- Sponsor
- Shanghai Henlius Biotech
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-26
- Primary completion
- 2023-08-31
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.